Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

r at the beginning of a Senate Judiciary Committee hearing with former FBI Director James Comey on Wednesday." The attorney, who works in the DOJ's Office of Intelligence (O1) "is not identified in the letter." The attorney signed "all four of the Foreign Intelligence Surveillance Act (FISA) warrants granted against P

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

r at the beginning of a Senate Judiciary Committee hearing with former FBI Director James Comey on Wednesday." The attorney, who works in the DOJ's Office of Intelligence (DI) "is not identified in the letter." The attorney signed "all four of the Foreign Intelligence Surveillance Act (PISA) warrants granted against P

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

r at the beginning of a Senate Judiciary Committee hearing with former FBI Director James Comey on Wednesday." The attorney, who works in the DOJ's Office of Intelligence (OI) "is not identified in the letter." The attorney signed "all four of the Foreign Intelligence Surveillance Act (FISA) warrants granted EFTA0014

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

r at the beginning of a Senate Judiciary Committee hearing with former FBI Director James Comey on Wednesday." The attorney, who works in the DOJ's Office of Intelligence (OI) "is not identified in the letter." The attorney signed "all four of the Foreign Intelligence Surveillance Act (FISA) warrants granted against